Pap test discrepancies and follow-up histology: Who's right and does it help to know?

Diagnostic Cytopathology

Volumn 29, Issue 2, 2003, Pages 111-115

  Stelow, Edward B ^a,d   Skeate, Robert ^a   Wahi, Monika M ^b   Kjeldahl, Klint ^c   McKeon, Dan ^c   Larkin, Stephen ^c   Woronzoff, Kristine ^a   Pambuccian, Stefan E ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Fairview Health System   (United States)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Cervical cytology; Cytohistologic correlation; Discrepancy rates; Pap test; Quality assurance

Indexed keywords

ARTICLE; COMPARATIVE STUDY; COMPETENCE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DOCUMENTATION; EVALUATION; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; LABORATORY PERSONNEL; MEDICAL RECORD; MEDICAL SPECIALIST; OBSERVER VARIATION; PAPANICOLAOU TEST; PATHOLOGIST; PATHOLOGY; PERFORMANCE; PRIORITY JOURNAL; REPRODUCIBILITY; UTERINE CERVIX DISEASE; VAGINA SMEAR;

DOCUMENTATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LABORATORY PERSONNEL; OBSERVER VARIATION; PATHOLOGY, CLINICAL; PROFESSIONAL COMPETENCE; QUALITY ASSURANCE, HEALTH CARE; REPRODUCIBILITY OF RESULTS; VAGINAL SMEARS;

EID: 0042737915     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.10332     Document Type: Article

References (11)

1. Bedrossian UK, Zaleski S. Cytotechnologist productivity standards: monitoring performance in a TQM environment. Diagn Cytopathol 1997;17:403-405.
2. Cibas ES, Dean B, Maffeo N, Allred EN. Quality assurance in gynecologic cytology. The value of cytotechnologist-cytopathologist discrepancy logs. Am J Clin Pathol 2001;115:512-516.
3. Condel JL, Mahood LK, Grzybicki DM, Sturgis CD, Raab SS. Papanicolaou tests diagnosed as atypical by a cytotechnologist and downgraded to benign by a pathologist: a measure of laboratory quality. Am J Clin Pathol 2002;117:534-540.
4. Stoler MH. Toward objective quality insurance: the eyes don't have it. Am J Clin Pathol 2002;117:520-522.
5. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-1610.
6. Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 2000;92:397-402.
7. Solomon D, Schiffman M, Tarone R. ASCUS LSIL Triage Study (ALTS) conclusions reaffirmed: response to a November 2001 commentary. Obstet Gynecol 2002;99:671-674.
8. Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-299.
9. Raab SS, Geisinger KR, Silverman JF, Thomas PA, Stanley MW. Interobserver variability of a Papanicolaou smear diagnosis of atypical glandular cells of undetermined significance. Am J Clin Pathol 1998; 110:653-659.
10. Renshaw AA, Lee KR, Granter SR. Use of statistical analysis of cytologic interpretation to determine the causes of interobserver disagreement and in quality improvement. Cancer 1997;81:212-219.
11. Stoler MH, Schiffman M. Atypical Squamous Cells of Undetermined Significance-Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001;285:1500-1505.